Dividend investing in healthcare, AbbVie’s 3

US $187.00
List price US $184.000 (57% off)
777 sold
This one's trending. 57187 have already sold.
Breathe easy. Returns accepted.

In healthcare, AbbVie’s 3.7% dividend yield is projected to be sustainable, as biosimilar competition impacts revenue slower than expected. This makes it a defensive dividend investing choice. The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. I/we have a beneficial long position in the shares of NNN, ET either through stock ownership, options, or other derivatives. REITs are regaining attention among dividend investing enthusiasts as U.S. rental markets stabilize. Realty Income’s current 5.2% yield remains above its 5-year average, signaling reliability in income streams.